Status:

UNKNOWN

Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury

Lead Sponsor:

Hamamatsu University

Conditions:

Kidney Failure

Eligibility:

All Genders

Brief Summary

We previously reported early measurement of urinary MDA might be a useful marker for the prediction of CDDP-induced renal damage in rat. The purpose of this clinical study is to test whether the chang...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Hospitalized patients have neck cancer

Exclusion

    Key Trial Info

    Start Date :

    Trial Type :

    OBSERVATIONAL

    End Date :

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT00310739

    Last Update

    November 7 2006

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hamamatsu University School of Medicine

    Hamamatsu, Shizuoka, Japan, 431-3192